Ekso Total Assets from 2010 to 2024

EKSO Stock  USD 1.31  0.02  1.55%   
Ekso Bionics Total Assets yearly trend continues to be very stable with very little volatility. Total Assets are likely to drop to about 26 M. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals
 
Total Assets  
First Reported
2012-06-30
Previous Quarter
31.2 M
Current Value
28.9 M
Quarterly Volatility
14.8 M
 
Yuan Drop
 
Covid
Check Ekso Bionics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ekso main balance sheet or income statement drivers, such as Interest Expense of 271.3 K, Selling General Administrative of 8.7 M or Other Operating Expenses of 28.5 M, as well as many exotic indicators such as Price To Sales Ratio of 1.8, Dividend Yield of 0.11 or PTB Ratio of 2.61. Ekso financial statements analysis is a perfect complement when working with Ekso Bionics Valuation or Volatility modules.
  
This module can also supplement Ekso Bionics' financial leverage analysis and stock options assessment as well as various Ekso Bionics Technical models . Check out the analysis of Ekso Bionics Correlation against competitors.

Latest Ekso Bionics' Total Assets Growth Pattern

Below is the plot of the Total Assets of Ekso Bionics Holdings over the last few years. Total assets refers to the total amount of Ekso Bionics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Ekso Bionics Holdings books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Ekso Bionics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ekso Bionics' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 28.92 M10 Years Trend
Slightly volatile
   Total Assets   
       Timeline  

Ekso Total Assets Regression Statistics

Arithmetic Mean22,221,136
Geometric Mean3,898,854
Coefficient Of Variation72.26
Mean Deviation12,707,428
Median24,425,000
Standard Deviation16,056,057
Sample Variance257.8T
Range49.2M
R-Value0.69
Mean Square Error146.7T
R-Squared0.47
Significance0
Slope2,465,597
Total Sum of Squares3609.2T

Ekso Total Assets History

202426 M
202328.9 M
202240.9 M
202149.2 M
202020.6 M
201921.9 M
201817.7 M

Other Fundumenentals of Ekso Bionics Holdings

Ekso Bionics Total Assets component correlations

0.9-0.81-0.740.770.990.380.370.09-0.550.740.360.560.670.59-0.650.380.50.190.090.190.18-0.46
0.9-0.84-0.560.410.920.230.170.48-0.410.560.140.450.480.47-0.420.180.350.070.050.460.44-0.49
-0.81-0.840.29-0.44-0.870.05-0.41-0.310.2-0.44-0.04-0.14-0.3-0.190.21-0.14-0.110.280.4-0.45-0.560.22
-0.74-0.560.29-0.74-0.7-0.65-0.070.190.79-0.75-0.62-0.89-0.77-0.930.95-0.5-0.9-0.36-0.330.340.350.64
0.770.41-0.44-0.740.710.460.52-0.52-0.540.730.540.50.70.55-0.730.530.540.30.13-0.28-0.29-0.25
0.990.92-0.87-0.70.710.320.350.14-0.560.710.340.510.610.56-0.620.380.460.04-0.030.220.26-0.43
0.380.230.05-0.650.460.320.24-0.29-0.640.590.240.720.180.69-0.690.260.620.530.39-0.47-0.61-0.08
0.370.17-0.41-0.070.520.350.24-0.380.120.22-0.270.0-0.13-0.11-0.02-0.09-0.040.05-0.11-0.2-0.190.5
0.090.48-0.310.19-0.520.14-0.29-0.380.25-0.19-0.37-0.02-0.1-0.060.33-0.42-0.24-0.060.020.740.7-0.26
-0.55-0.410.20.79-0.54-0.56-0.640.120.25-0.66-0.71-0.65-0.5-0.760.9-0.82-0.68-0.12-0.110.280.270.39
0.740.56-0.44-0.750.730.710.590.22-0.19-0.660.320.630.670.63-0.790.450.690.240.17-0.04-0.11-0.38
0.360.14-0.04-0.620.540.340.24-0.27-0.37-0.710.320.340.650.6-0.680.690.440.050.04-0.34-0.29-0.58
0.560.45-0.14-0.890.50.510.720.0-0.02-0.650.630.340.560.94-0.840.280.910.470.35-0.35-0.39-0.53
0.670.48-0.3-0.770.70.610.18-0.13-0.1-0.50.670.650.560.64-0.710.420.620.290.330.020.0-0.78
0.590.47-0.19-0.930.550.560.69-0.11-0.06-0.760.630.60.940.64-0.90.390.890.350.22-0.38-0.39-0.66
-0.65-0.420.210.95-0.73-0.62-0.69-0.020.330.9-0.79-0.68-0.84-0.71-0.9-0.66-0.88-0.27-0.210.410.390.52
0.380.18-0.14-0.50.530.380.26-0.09-0.42-0.820.450.690.280.420.39-0.660.360.050.01-0.14-0.11-0.15
0.50.35-0.11-0.90.540.460.62-0.04-0.24-0.680.690.440.910.620.89-0.880.360.260.22-0.48-0.46-0.61
0.190.070.28-0.360.30.040.530.05-0.06-0.120.240.050.470.290.35-0.270.050.260.83-0.07-0.4-0.15
0.090.050.4-0.330.13-0.030.39-0.110.02-0.110.170.040.350.330.22-0.210.010.220.83-0.01-0.3-0.22
0.190.46-0.450.34-0.280.22-0.47-0.20.740.28-0.04-0.34-0.350.02-0.380.41-0.14-0.48-0.07-0.010.93-0.06
0.180.44-0.560.35-0.290.26-0.61-0.190.70.27-0.11-0.29-0.390.0-0.390.39-0.11-0.46-0.4-0.30.93-0.06
-0.46-0.490.220.64-0.25-0.43-0.080.5-0.260.39-0.38-0.58-0.53-0.78-0.660.52-0.15-0.61-0.15-0.22-0.06-0.06
Click cells to compare fundamentals

About Ekso Bionics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Ekso Bionics income statement, its balance sheet, and the statement of cash flows. Ekso Bionics investors use historical funamental indicators, such as Ekso Bionics's Total Assets, to determine how well the company is positioned to perform in the future. Although Ekso Bionics investors may use each financial statement separately, they are all related. The changes in Ekso Bionics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Ekso Bionics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Ekso Bionics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Ekso Bionics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Assets28.9 M26 M
Intangibles To Total Assets 0.18  0.19 

Pair Trading with Ekso Bionics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ekso Bionics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ekso Bionics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Ekso Stock

  0.78OM Outset MedicalIncPairCorr

Moving against Ekso Stock

  0.83EHC Encompass Health CorpPairCorr
  0.78DXCM DexCom IncPairCorr
  0.72BSX Boston Scientific CorpPairCorr
  0.67HIMS Hims Hers Health Financial Report 13th of May 2024 PairCorr
  0.65SEM Select Medical HoldingsPairCorr
The ability to find closely correlated positions to Ekso Bionics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ekso Bionics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ekso Bionics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ekso Bionics Holdings to buy it.
The correlation of Ekso Bionics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ekso Bionics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ekso Bionics Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ekso Bionics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Ekso Bionics Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ekso Bionics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ekso Bionics Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ekso Bionics Holdings Stock:
Check out the analysis of Ekso Bionics Correlation against competitors.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for Ekso Stock analysis

When running Ekso Bionics' price analysis, check to measure Ekso Bionics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ekso Bionics is operating at the current time. Most of Ekso Bionics' value examination focuses on studying past and present price action to predict the probability of Ekso Bionics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ekso Bionics' price. Additionally, you may evaluate how the addition of Ekso Bionics to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Commodity Directory
Find actively traded commodities issued by global exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Is Ekso Bionics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ekso Bionics. If investors know Ekso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ekso Bionics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.97)
Revenue Per Share
1.202
Quarterly Revenue Growth
(0.09)
Return On Assets
(0.26)
Return On Equity
(0.20)
The market value of Ekso Bionics Holdings is measured differently than its book value, which is the value of Ekso that is recorded on the company's balance sheet. Investors also form their own opinion of Ekso Bionics' value that differs from its market value or its book value, called intrinsic value, which is Ekso Bionics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ekso Bionics' market value can be influenced by many factors that don't directly affect Ekso Bionics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ekso Bionics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ekso Bionics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ekso Bionics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.